How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Biobanking Services Market
- By Sample Type: Human Tissue Biobanking, Blood and Blood Derivatives Biobanking, DNA/RNA Biobanking, Microbial Biobanking, Cell Line Biobanking
- By Service Type: Sample Collection and Processing, Sample Storage and Preservation, Sample Distribution and Logistics, Data Management and Annotation, Quality Control and Assurance
- By End User: Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Hospitals and Clinical Research Organizations, Government and Public Health Agencies, Contract Research Organizations (CROs)
- By Storage Method: Cryogenic Storage, Mechanical Freezer Storage, Liquid Nitrogen Storage, Ambient Temperature Storage
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Human Tissue Biobanking leads By Sample Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
11 chapters · 279 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.63 →
- 10 Competitive Landscape 5 sections p.168 →
- 11 Company Profiles 15 players: SWOT & benchmarking p.176 →
Full report · locked preview
Everything inside the Biobanking Services Market report
A complete, evidence-based study - 11 chapters and 117 sections covering market size, segmentation across 4 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Sample Type 5
Service Type 5
End User 5
Storage Method 4
Companies profiled
Thermo Fisher Scientific
Sartorius AG
Brooks Life Sciences
QIAGEN N.V.
Corning Incorporated
BioStorage Technologies
Roche Diagnostics
Agilent Technologies
Nexcelom Bioscience
Biocair
Axol Bioscience
BioreclamationIVT
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Thermo Fisher Scientific
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Sartorius AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Brooks Life Sciences
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →QIAGEN N.V.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Corning Incorporated
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →BioStorage Technologies
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Roche Diagnostics
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Agilent Technologies
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Nexcelom Bioscience
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Biocair
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Axol Bioscience
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →BioreclamationIVT
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Cytiva
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Biomatrica
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Biobank Japan
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$887.8M by 2033 · 4.3% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Human Tissue Biobanking38.4
- Blood and Blood Derivatives Biobanking14.0
- DNA/RNA Biobanking13.7
- Microbial Biobanking16.7
- Cell Line Biobanking17.3
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$209.6M → $274.7M · 3.4%
Europe$146.1M → $218.7M · 5.2%
Asia Pacific$133.4M → $171.6M · 3.2%
Latin America$82.6M → $129.9M · 5.8%
Middle East and Africa$63.5M → $98.8M · 5.7%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →4.232026
4.252027
4.262028
4.262029
4.272030
4.292031
4.302032
4.312033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Thermo Fisher Scientific19.4
- Sartorius AG18.9
- Brooks Life Sciences9.0
- QIAGEN N.V.9.3
- Corning Incorporated3.9
- BioStorage Technologies11.5
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Sample Type21.4%
Service Type33.5%
End User30.5%
Storage Method14.7%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America30.7
- Europe24.5
- Asia Pacific19.2
- Latin America14.5
- Middle East and Africa11.1
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Thermo Fisher Scientific | 82 | 92 | 91 | 75 | 88 | 75 | 84 |
| Sartorius AG | 79 | 75 | 82 | 74 | 84 | 76 | 78 |
| Brooks Life Sciences | 77 | 71 | 81 | 78 | 80 | 71 | 76 |
| QIAGEN N.V. | 65 | 77 | 61 | 58 | 66 | 76 | 67 |
| Corning Incorporated | 60 | 71 | 63 | 75 | 72 | 60 | 67 |
| BioStorage Technologies | 53 | 63 | 53 | 61 | 62 | 46 | 56 |
| Roche Diagnostics | 55 | 47 | 44 | 57 | 60 | 42 | 51 |
| Agilent Technologies | 53 | 45 | 53 | 40 | 54 | 53 | 50 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Thermo Fisher Scientific
- Sartorius AG
- Brooks Life Sciences
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific | ◐ | ✓ | ✓ | ✓ | ◐ | ◐ |
| Sartorius AG | ◐ | ✓ | ◐ | ✓ | ✓ | ◐ |
| Brooks Life Sciences | ◐ | ✓ | ✓ | ◐ | ◐ | ◐ |
| QIAGEN N.V. | ◐ | ◐ | − | ◐ | ◐ | ✓ |
| Corning Incorporated | − | ◐ | ◐ | − | ✓ | − |
| BioStorage Technologies | ◐ | ✓ | ◐ | ◐ | − | − |
| Roche Diagnostics | − | − | − | ◐ | ◐ | − |
| Agilent Technologies | ◐ | − | ◐ | − | − | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Thermo Fisher Scientific84
2Sartorius AG78
3Brooks Life Sciences76
4QIAGEN N.V.67
5Corning Incorporated67
6BioStorage Technologies56
7Roche Diagnostics51
8Agilent Technologies50
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Thermo Fisher ScientificSartorius AG
Challenger3
Strong scale, closing on the leaders.
Brooks Life SciencesQIAGEN N.V.Corning Incorporated
Niche3
Specialists in a single segment or region.
BioStorage TechnologiesRoche DiagnosticsAgilent Technologies
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Sample Type in North America, then scale across Biobanking Services Market — a $393M beachhead inside a $6.16B market.
Beachhead (SOM)$393Mobtainable near-term
Serviceable (SAM)$2.31Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale4 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion89 fit
Human Tissue Biobanking
Best fit — highest urgency & budget in Sample Type.
Economic buyer76 fit
Blood and Blood Derivatives Biobanking
Strong fit — clear ROI and a fast path to value.
End user67 fit
DNA/RNA Biobanking
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Sample Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Service Type & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End User
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales46%
Partner / channel26%
Digital / self-serve21%
Marketplaces7%
Positioning & messaging
§GTM 2 · p.194 →For Sample Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Biobanking Services Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified40%
Sales qualified22%
Evaluation13%
Closed-won5%
$15.5KCAC
$54KLTV
3.5:1LTV : CAC
< 3 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Biobanking Services Market is a durable-growth opportunity — $4.43B by 2033, compounding at 9.1%.
TAM · 2025$2.20Btoday
TAM · 2033$4.43Bforecast
CAGR9.1%2027–2033
Cumulative$28.8Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$4.43BTotal addressable market
SAM$1.56BServiceable available market
SOM$303MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →9.1% CAGR
Demand compounds through 2033, outpacing GDP across Sample Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Sample Type moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$4.43BLarge & growingTAM by 2033 at 9.1% CAGR
$1.56BServiceable nowreachable with today’s model
$303MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$3.45BBear5.9% CAGR
$4.43BBase9.1% CAGR
$5.66BBull12.0% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Service Type optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Biobanking Services Market — a $4.47B market by 2033. Plan: grow share from 6.1% to 12.8%.
Market size · 2033$4.47Btotal addressable
Market CAGR7.2%2027–2033
Target share12.8%from 6.1% today
Revenue ambition$573Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 6.1% | 12.8% | On track |
| Revenue | $282M | $573M | Ahead |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Ahead |
| Segment coverage | 2 of 4 axes | 4 of 4 axes | On track |
| Gross margin | 32.6% | 41.8% | On track |
| Customer retention | 91.7% | 93.8% | At risk |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Sample Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Service Type capability
A defensible second engine — invest in Service Type to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Sample Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Service Type
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $69M capacity & capability investment
- Greenlight bolt-on M&A in Service Type
- Authorise North America expansion plan
- Fund R&D program for Sample Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossAt risk
- Input-cost & supply riskOn track
- Regulatory / policy changeAt risk
- Execution & talentAt risk
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Biobanking Services Market conversation — a $892M market you can size, segment and defend in minutes.
Market size · 2033$892Mtotal opportunity
Growth5.9%CAGR to 2033
Addressable buyers1,600+accounts in scope
Typical ROI4.7×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Sample Type
Goal Grow share in Sample Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →4.7×return on cost, year one
< 3 mopayback period
$78K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
Thermo Fisher ScientificSartorius AGBrooks Life SciencesQIAGEN N.V.Corning IncorporatedBioStorage TechnologiesRoche DiagnosticsAgilent Technologies+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Biobanking Services Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Biobanking Services Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Wearable Wireless Patch Device Market
Market size, share, segmentation and regional forecast.
$3.6B market · 2025 base year
View reportHemodialysis Vascular Access (Stent) Market
Market size, share, segmentation and regional forecast.
$2.5B market · 2025 base year
View reportHemodialysis Vascular Access Market
Market size, share, segmentation and regional forecast.
$2.2B market · 2025 base year
View reportHemodialysis Tubing Set Market
Market size, share, segmentation and regional forecast.
$6.1B market · 2025 base year
View reportHemodialysis Tubing Market
Market size, share, segmentation and regional forecast.
$2.7B market · 2025 base year
View reportHemodialysis Tubing Clamp Market
Market size, share, segmentation and regional forecast.
$6.3B market · 2025 base year
View reportHemodialysis Tube Market
Market size, share, segmentation and regional forecast.
$4.9B market · 2025 base year
View reportHemodialysis Solutions Market
Market size, share, segmentation and regional forecast.
$3.0B market · 2025 base year
View reportHemodialysis Service Market
Hemodialysis Service Market is valued at USD 10.24 Billion in 2025 and is expected to reach USD…
$10.2B market · 2025 base year
View reportHemodialysis Powder Market
Market size, share, segmentation and regional forecast.
$1.2B market · 2025 base year
View reportHemodialysis Needle Set Market
Market size, share, segmentation and regional forecast.
$5.8B market · 2025 base year
View reportHemodialysis Medical Service Market
Market size, share, segmentation and regional forecast.
$2.3B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.